| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1027342B1 Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1021418B1 Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0984965B1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 05/19/2004 | EP0942722B1 Tetrahydro-beta-carboline compounds |
| 05/19/2004 | EP0941227B1 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent |
| 05/19/2004 | EP0921790B1 Sulfonyl fluorides for the treatment of alzheimer's disease |
| 05/19/2004 | EP0888323B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/19/2004 | EP0874629B1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS |
| 05/19/2004 | EP0870026B1 Ob protein derivatives having prolonged half-life |
| 05/19/2004 | EP0801572B1 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 05/19/2004 | EP0781136B1 Compounds and methods for the treatment of cancer |
| 05/19/2004 | EP0637237B1 Calcium receptor-active molecules |
| 05/19/2004 | EP0608433B1 Composition for dermatologic preparation |
| 05/19/2004 | DE60101056T2 Verfahren zur Herstellung von Ribavirin Process for the preparation of ribavirin |
| 05/19/2004 | DE60100389T2 Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung Fat-soluble substances containing granules, and processes for their preparation |
| 05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
| 05/19/2004 | DE20220838U1 Orale Arzneiform enthaltend einen therapeutischen Wirkstoff und ein Gegenwirkungsmittel Oral dosage form containing a therapeutic agent and a counteracting means |
| 05/19/2004 | DE202004004618U1 Composition containing bilberry extract, useful for treating headache and migraine, also contains antioxidants and micronutrients |
| 05/19/2004 | DE10251028A1 Verwendung von Progesteron oder einem Progesteronrezeptor-Agonisten zur Hemmung der Steroidsynthese Use of progesterone or a progesterone receptor agonists for the inhibition of steroid synthesis |
| 05/19/2004 | DE10250710A1 Neue Verwendung von Dioxocin-5-on-Derivaten New use of dioxocin-5-one derivatives |
| 05/19/2004 | DE10250543A1 Mehrschichtige Arzneiform Multilayer dosage form |
| 05/19/2004 | DE10236564A1 Verwendung von papaverinartigem Vasodilatator und pharmazeutische Zusammensetzung Use of papaverinartigem vasodilator and pharmaceutical composition |
| 05/19/2004 | DE10048715A1 Verwendung von Aminosäure zur Behandlung von Schmerz Using amino acid for treating pain |
| 05/19/2004 | CN1498245A Highly nucleated thermoplastic articles |
| 05/19/2004 | CN1498237A Process for preparing lactic acid oligomer |
| 05/19/2004 | CN1498224A Novel peptides as NS3-serine protease inhibitors of hepatitiscvirus |
| 05/19/2004 | CN1498222A Steroidal derivatives |
| 05/19/2004 | CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 05/19/2004 | CN1498219A Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b] quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl) acetamide |
| 05/19/2004 | CN1498218A Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498216A Noval crystal and solvate forms of ondansetron hydrochloride and process for their preparation |
| 05/19/2004 | CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1498211A Aniline derivative using as phosphodiesterase 4 inhibitor |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498209A 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 05/19/2004 | CN1498206A Biurethane derivatives |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1498114A Pharmaceutical composition having reduced tendency for drug crystallization |
| 05/19/2004 | CN1498112A Combination therapy for estrogen-dependent disorders |
| 05/19/2004 | CN1498110A Remedies for vesical hyperfunction |
| 05/19/2004 | CN1498109A Remedies for cysterethsm |
| 05/19/2004 | CN1498108A Nicotinic receptor agonists for treatment of inflammatory diseases |
| 05/19/2004 | CN1498107A Combination of taxane and cyclin-dependent kinase inhibitor |
| 05/19/2004 | CN1498106A Pharmaceutical forms of epothilones for oral administration |
| 05/19/2004 | CN1498105A Synergistic combinations of vitaminosis A receptor ligands and selected cytotoxic agents for treatment of cancer |
| 05/19/2004 | CN1498104A Novel application of peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 05/19/2004 | CN1498103A Novel use of peptide class of compound for treating non-neuropathic inflammatory pain |
| 05/19/2004 | CN1498102A Anti-atherosclerosis composition containing carotenoilds and method for inhibiting LDL oxidation |
| 05/19/2004 | CN1498096A Condom with erectogenic composition |
| 05/19/2004 | CN1498084A Low glycemic response compositions |
| 05/19/2004 | CN1498080A One-step process for preparing gum |
| 05/19/2004 | CN1496989A New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1496986A Industrial synthetising strontium salt and method of its hydrate |
| 05/19/2004 | CN1496982A Imidazoline compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1496980A N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/19/2004 | CN1496743A Medicine composition of adding active component which undissolved in water in carrier composition and its preparing method |
| 05/19/2004 | CN1496742A Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 05/19/2004 | CN1496741A Method for producing enteric nutrient containing malt ketose |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/19/2004 | CN1496738A Fenofibrate medicine composition with high bio-availability and preparation method thereof |
| 05/19/2004 | CN1496737A Method for treating inflammation of muscular skeleton and connective tissue |
| 05/19/2004 | CN1496736A Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite |
| 05/19/2004 | CN1150404C Inhibition of Tau-Tau association |
| 05/19/2004 | CN1150328C Method for constituting genetically engineered cell strain and bacterial strain for vaccine of hepatitis B |
| 05/19/2004 | CN1150217C Cross-linked polymer and its application |
| 05/19/2004 | CN1150204C Cyclobornane triterpenoid saponin compound and its application in immunosuppresion and treating tumor |
| 05/19/2004 | CN1150202C Nwe tylosin hydroxyl derivative and its producing process |
| 05/19/2004 | CN1150201C L-arabino-disaccharides of anthracyclines, Process for their preparation, and pharmaceutical compositions containing them |
| 05/19/2004 | CN1150197C Naphtho- and dihydrobenzo-thiopyhene derivatives as cytotoxic antitumor agents |
| 05/19/2004 | CN1150196C Morphinane derivatives and medicinal use thereof |
| 05/19/2004 | CN1150195C Bicyclic nitrogen heterocycles |
| 05/19/2004 | CN1150194C Carbocyclic nucleoside hemisufate and its use in treating viral infectiosn |
| 05/19/2004 | CN1150193C Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diaxabicyclo[4.3.o]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150191C Aminoalkyl substituted benzodioxan derivatives |
| 05/19/2004 | CN1150190C 4-(caminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| 05/19/2004 | CN1150189C Benzopyranone and benzodihydropyranon derivatives as integrin inhibitors |
| 05/19/2004 | CN1150187C Use of selective antagonists of a1b-adrenergic receptor for improvement of sexual dysfunction |
| 05/19/2004 | CN1150186C 苯并咪唑化合物结晶 Benzimidazole compound crystallized |
| 05/19/2004 | CN1150185C Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositiions contg. said compounds and use thereof |
| 05/19/2004 | CN1150183C New heterocylic tertiary amines, process for their preparation and pharmaceutical compositions containing them |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150178C Sidechain-bearing taxanes |
| 05/19/2004 | CN1150176C Aralkylone pipeazine derivative and its application |
| 05/19/2004 | CN1150175C Derivatives of 1,3,4-oxadiazolone |
| 05/19/2004 | CN1150172C 1,5 benzodiazepine derviatives |
| 05/19/2004 | CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/19/2004 | CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders |
| 05/19/2004 | CN1150162C Biphenylamidine derivatives |
| 05/19/2004 | CN1150159C Intermediate for preparing allyl quinone derivative and prep. of the same |